作者
Asma Ejaz, Laura Martinez-Guino, Allison B Goldfine, Francesc Ribas-Aulinas, Valeria De Nigris, Sílvia Ribó, Alba Gonzalez-Franquesa, Pablo M Garcia-Roves, Elizabeth Li, Jonathan M Dreyfuss, Walt Gall, Jason K Kim, Teodoro Bottiglieri, Francesc Villarroya, Robert E Gerszten, Mary-Elizabeth Patti, Carles Lerin
发表日期
2016/4/1
期刊
Diabetes
卷号
65
期号
4
页码范围
902-912
出版商
American Diabetes Association
简介
Identifying markers of human insulin resistance may permit development of new approaches for treatment and prevention of type 2 diabetes. To this end, we analyzed the fasting plasma metabolome in metabolically characterized human volunteers across a spectrum of insulin resistance. We demonstrate that plasma betaine levels are reduced in insulin-resistant humans and correlate closely with insulin sensitivity. Moreover, betaine administration to mice with diet-induced obesity prevents the development of impaired glucose homeostasis, reduces hepatic lipid accumulation, increases white adipose oxidative capacity, and enhances whole-body energy expenditure. In parallel with these beneficial metabolic effects, betaine supplementation robustly increased hepatic and circulating fibroblast growth factor (Fgf)21 levels. Betaine administration failed to improve glucose homeostasis and liver fat content in Fgf21 …
引用总数
20162017201820192020202120222023202438111216202167